Press 07.12.2022 Bicycle Therapeutics Announces Publication of Article Highlighting Preclinical Data from BT7480 Program in the Journal of Medicinal Chemistry
Press 07.12.2022 Bicycle Therapeutics Announces Further Expansion of Genentech Immuno-Oncology Collaboration
Press 06.08.2022 Bicycle Therapeutics Announces First Patient Dosed in Expansion Cohorts of Phase I/II Trial of Bicycle® Toxin Conjugate BT5528 in...
